Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78,783,577
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
11,793,247
-
Shares change
-
+440,382
-
Total reported value, excl. options
-
$54,910,109
-
Value change
-
+$1,590,384
-
Put/Call ratio
-
70.6%
-
Number of buys
-
33
-
Number of sells
-
-31
-
Price
-
$4.65
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q3 2021
93 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q3 2021.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,793,247 shares
of 78,783,577 outstanding shares and own 14.97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,506,394 shares), VANGUARD GROUP INC (1,810,946 shares), Elliott Investment Management L.P. (1,550,523 shares), CREDIT SUISSE AG/ (750,439 shares), STATE STREET CORP (696,515 shares), GEODE CAPITAL MANAGEMENT, LLC (671,003 shares), NOMURA HOLDINGS INC (436,639 shares), MORGAN STANLEY (367,493 shares), NORTHERN TRUST CORP (343,238 shares), and Cresset Asset Management, LLC (329,796 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.